Tiziana Life Sciences Ltd (TLSA)
TLSA Stock Price Chart
Explore Tiziana Life Sciences Ltd interactive price chart. Choose custom timeframes to analyze TLSA price movements and trends.
TLSA Company Profile
Discover essential business fundamentals and corporate details for Tiziana Life Sciences Ltd (TLSA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Nov 2018
Employees
9.00
CEO
Ivor R. Elrifi
Description
Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.
TLSA Financial Timeline
Browse a chronological timeline of Tiziana Life Sciences Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Sept 2026
EPS estimate is -$0.08.
Earnings released on 1 May 2026
EPS came in at -$0.22 falling short of the estimated -$0.09 by -143.01%.
Earnings released on 13 Oct 2025
Earnings released on 8 Jul 2025
EPS came in at -$0.10 falling short of the estimated -$0.07 by -35.38%.
Earnings released on 23 Jun 2025
EPS came in at -$0.13 .
Earnings released on 20 May 2025
EPS came in at -$0.06 .
Earnings released on 18 Oct 2024
Earnings released on 30 Jun 2024
EPS came in at -$0.18 .
Earnings released on 11 May 2024
Earnings released on 11 May 2024
EPS came in at -$0.18 .
Earnings released on 26 Dec 2023
EPS came in at -$0.17 .
Earnings released on 3 Oct 2023
Earnings released on 26 Apr 2023
Earnings released on 26 Apr 2023
EPS came in at -$0.22 .
Earnings released on 27 Dec 2022
EPS came in at -$0.09 .
Stock split effective on 21 Oct 2021
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Sept 2021
EPS came in at -$0.20 falling short of the estimated -$0.06 by -253.17%.
Earnings released on 24 Sept 2021
EPS came in at -$0.20 falling short of the estimated -$0.06 by -253.17%.
TLSA Stock Performance
Access detailed TLSA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
